Medical Equipment News

Main Category: Respiratory / Asthma Also Included In: Infectious Diseases / Bacteria / Viruses Article Date: 18 Nov 2009 Aradigm Corporation announced that the first patient was dosed in a 6-month, multicenter, international Phase 2 clinical trial of a novel version of inhaled ciprofloxacin in 40 adult patients with non-cystic fibrosis ...

The following stocks were among those that moved substantially or traded heavily Wednesday on the New York Stock Exchange: NYSE: Coventry Health Care Inc., down 63 cents at $23.05 An analyst said the health insurer will likely offer a disappointing 2010 earnings outlook and may be hit hard by health care reforms.

Robotic surgical device maker Intuitive Surgical Inc. said Friday its da Vinci S system received regulatory approval in Japan.

For the loneliest number, one sure has a lot of company. A one point gain took the Standard & Poor's 500 Index to within one percent of its retracement level while one dollar will suffice as a salary for Citigroup's CEO.

Advanced heart failure patients who received Thoratec Corp's new pump awaiting U.S. approval as an alternative to heart transplants lived longer and fared far better than those getting the company's older HeartMate XVE device, researchers said on Tuesday.

Medtronic, Inc. today announced the kick-off of an educational campaign aimed at raising awareness among women of overactive bladder , a serious condition that can severely impact patients' lives.

Shanghai Fosun Pharmaceuticals Co., or Fosun Pharma, rises slightly Thursday morning at the Shanghai Stock Exchange after it announced to have bought stake in the Nasdaq-listed Chindex International Inc.

OraSure Technologies Inc., which makes diagnostic kits to detect HIV and drug use, said Thursday it will pay Inverness Medical $3 million to settle a patent dispute over HIV tests.

Thoratec Corporation , a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said that data released from the Destination Therapy pivotal trial for the HeartMate II left ventricular assist system demonstrate that the device achieved statistically superior results over the HeartMate XVE, ...

ZOLL Medical Corporation announced today that in a a oeBest of the Besta presentation at the American Heart Association Resuscitation Science Symposium in Orlando Florida, Daniel P. Davis, M.D., presented research from the University of California Resuscitation Research Center that shows a major improvement in patient outcome after cardiac arrest.

Delcath Systems Inc., a developer of a cancer-drug delivery device, said Wednesday it raised $32.4 million in net proceeds from a public stock offering.

A Houston-based oil and gas drilling company facing complaints of racial discrimination has been ordered to turn over its personnel records as part of an Equal Employment Opportunity Commission investigation.

FILE - In this Aug. 16, 2005, the "Rising Man" symbol stands in front of the Fridley, Minn., based... FILE - In this Aug.

MOUNTAIN VIEW, Calif. -- For men who want sex now, but um, can't quite get the equipment working fast enough, Vivus might have a new drug for you.

Pacing the two lower chambers of the heart, or bi-ventricular pacing, prevented cardiac enlargement as compared to only pacing the right ventricle in pacemaker patients with normal pumping hearts, according to results presented from the Pacing to Avoid Cardiac Enlargement trial, a clinical study supported by Medtronic, Inc.

Main Category: Blood / Hematology Also Included In: Clinical Trials / Drug Trials Cerus Corporation announced that the FDA's Blood Products Advisory Committee rendered a positive opinion on the proposed hemostatic efficacy and safety endpoints for a potential U.S. Phase III clinical trial of the INTERCEPT Blood System for platelets.

Orthopedic device maker Wright Medical Group Inc. said Monday it named Lance A. Berry senior vice president and chief financial officer, replacing outgoing financial chief John K. Bakewell.

Shares of digital mammogram system maker Hologic Inc. fell Tuesday after a government task force recommended that women wait longer before having mammograms, and have the breast examinations less often.

These new screws represent the latest advance in biocomposite material technology that allows CONMED Linvatec to produce the smallest Biocomposite Interference screw available on the market today for primary fixation of ACL and PCL grafts.

Antares Pharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released 2009-11-16 06:19:20 - Antares Pharma, Inc.